Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

OTLK

OTLK News

Newswire

09:08

Outlook Therapeutics to present at Piper Sandler Healthcare Conference.

10:44

Outlook Therapeutics shares rise 16.24% intraday after FDA accepts resubmitted BLA for ONS-5010, a potential first FDA-approved ophthalmic bevacizumab for wet AMD.

09:55

Outlook Therapeutics shares rise 12.93% intraday as FDA accepts resubmission of ONS-5010 biologics license application for wet AMD with December 31, 2025 PDUFA date.

04:48

Outlook Therapeutics shares rise 14.06% premarket after FDA accepts BLA resubmission for ONS-5010 wet AMD treatment.

03:36

FDA Accepts Resubmitted BLA for ONS-5010 in Wet AMD, Decision Due This Month

View More

About OTLK

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More